 |
Small Molecule Bruton’s Agammaglobulinemia Tyrosine Kinase (BKT) Inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Pemphigus vulgaris |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-29 00:00:00 |
| Sponsor | Principia Biopharma Inc.;400 East Jamie Court;South San Francisco, California, 94080 |
